thumbnail image
broken image
broken image
broken image

Dr. Charleson S. Bell

  • HOME
  • RESEARCH
  • VENTURES
  • ENTERTAINMENT
  • …  
    • HOME
    • RESEARCH
    • VENTURES
    • ENTERTAINMENT
KEEP UP
broken image
broken image
broken image

Dr. Charleson S. Bell

  • HOME
  • RESEARCH
  • VENTURES
  • ENTERTAINMENT
  • …  
    • HOME
    • RESEARCH
    • VENTURES
    • ENTERTAINMENT
KEEP UP
broken image
  • broken image

    RESEARCH ASSISTANT PROFESSOR

    Dr. Bell possesses the expertise, leadership, and motivation necessary to successfully carry out the biomedical research that will improve outcomes. He completed his PhD at Vanderbilt University in Biomedical Engineering with an emphasis in bionanotechnology. Infusing novel bionanotechnology into current medical systems, devices and other more specified applications for an increase in point-of-care ability, efficiency, and ease of use has been his dream since adolescence.

     

    He culminated his previous studies in low analyte detection of cancer biomarkers and the fabrication of novel multilayered magnetometallodielectic nanoparticles to propel his work towards more imminent needs. This led to his current studies which include the rapid diagnosis and treatment of multi-drug resistant bacteria, where he devised the strategy behind an innovation for rapid, smartphone-compatible, nosocomial biofilm detection. He extended this innovation into a design for a rapid, at-home, SARS-Cov-2 (COVID-19) sputum/saliva detection test.

    READ MORE
  • NOTABLE SCIENTIFIC CONTRIBUTIONS

    Selected media showcasing some of Dr. Bell's scientific contributions

    Public Dissertation Defense

    Charleson S. Bell, Ph.D. defends his Dissertation entitled "Novel Multilayered Magnetoplasmonic Nanoparticles for Theranostic Applications" to the public for the degree of Doctor of Philosophy in Biomedical Engineering.

    broken image

    Frontispiece Accolade

    High-impact published research is normally recognized through a feature on a journal's cover, inside cover or frontispiece. Dr. Bell's first peer-reviewed, first-author publication was recognized as high impact work as it was featured on the frontispiece of one of the highest-impact journals for nanotechnology.

    broken image

    Impact Publication

    This publication described an innovative approach which used an antibiotic, instead of conventional targeting motifs (antibodies, DNA, or aptamers), to target the surface of bacteria for capture. This particular species of bacteria has a proclivity towards multi-drug resistance, increasing the impact of this research.

  • FOLLOW ME FOR REAL-TIME UPDATES

    ...only a button click away...

    FOLLOW ME
broken image

About Me

My Mission

Looking for Partners

News

Bell Siblings

Innovator at VU

Contact Me

Email

© 2020 Dr. Charleson S. Bell

    Home
    LinkedIn
    Twitter
    Instagram
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More